Galantamine

Amber

Brand Name(s):Reminyl

Indication:Dementia

Rationale:1,5,6

Considered:Jan-07

Review Date:Jun-23

Comments:
Updated NICE NG97
Dementia: assessment, management and support for people living with dementia and their carers
June 2018
…………………………
Update NICE CG42
Dementia: supporting people with dementia and their carers in health and social care
Sept 2016
…………………………
Updated TA217
Galantamine for the treatment of Alzheimer’s disease
May 2016
…………………………
Drug Safety Update
Serious skin reactions have been reported.
January 2016